10-Q quarterly report · filed Oct 27, 2026

CTS CORP (CTS) Q3 2026 10-Q Quarterly Report

Short answer

CTS CORP (CTS) filed its Q3 2026 10-Q quarterly report on Oct 27, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $150M (up 4.6% year over year) with net income of $18M.

Q3 2026 key financials · XBRL

Revenue
$150M
+4.6% YoY · +3.3% QoQ
Net income
$18M
+29.7% YoY · −7.3% QoQ
Operating margin
17.1%
Gross margin
42.2%
EPS (diluted)
$0.61
+32.6% YoY · −9.0% QoQ

Source: XBRL data from the CTS CORP (CTS) Q3 2026 10-Q on SEC EDGAR. USD.

CTS CORP Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $149.6M, up 4.6% YoY from $143.0M, diversified markets up 6.6%
  • Gross margin 42.2% vs 38.7%; operating margin 17.1% vs 14.7%
  • Medical and industrial growth strongest; aerospace and defense declined on contract-award timing
  • Cash $143.9M vs $82.3M at December 31; operating cash flow $94.3M through nine months
  • Millar acquisition for $50.0M, up to $20.0M contingent consideration; tariffs, market softness and geopolitical risks remain headwinds

Risk Factors

  • No material changes to risk factors from the December 31, 2025 Form 10-K
  • Continued risks include competitive pressure, based on carried-forward disclosures
  • Continued risks include regulatory and legal compliance exposure, based on carried-forward disclosures
  • Continued risks include liquidity, debt, and market exposure, based on carried-forward disclosures

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other CTS CORP quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.